Programs

Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department

/0 Comments/in , /by

The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event.

This ACEP Chapter Educational Lecture Series offers clinical pearls for the assessment of bleeding severity in patients receiving DOACs; expert-guided insights to rapid reversal of urgent DOAC-associated bleeding; and clinical decision support tools to optimize outcomes in patients requiring reversal of DOACs.

For more information about this program or other Spire Learning programs, please contact us at info@spirelearning.com or call 973-605-2922

Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department – Maryland

/0 Comments/in , /by

For more information about this program or other Spire Learning programs, please contact us at info@spirelearning.com or call 973-605-2922

Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department – Illinois

/0 Comments/in , /by

For more information about this program or other Spire Learning programs, please contact us at info@spirelearning.com or call 973-605-2922

Advances in the Multidisciplinary Care of Patients with Tenosynovial Giant Cell Tumor – Gather-ed Activity

/0 Comments/in , /by

Tenosynovial giant cell tumor (TGCT), a rare, nonmalignant tumor, arises from synovium in joints, bursae, and tendon sheaths. The diffuse type often presents aggressively, with high recurrence rates following surgery. The FDA recently approved the first medication for adult patients with symptomatic TGCT associated with severe morbidity or functional limitations and not amenable to improvement with surgery. Individualized treatment plans should be created for patients by evaluating the benefits and risks of surgery and medications, as well as the type and severity of the disease and patient-specific characteristics.

This activity will be delivered via an innovative online platform and led by faculty experts in TGCT using virtual small groups of learners to drive discussion and learning through assessments, self-study modules, group tasks, and live group discussions.

Here is the link to sign up with additional details.  Once on the platform, pick a group to enroll in.  The groups will be kicking off in early to mid-January.  Don’t wait, sign up today!

https://spire.gathered.com/curriculum/47

 

The Time Is Now: Advancing the Care of Adolescent and Adult Patients With Sickle Cell Disease

/0 Comments/in /by

Did you know the average life span of Americans with sickle cell disease is 20 to 30 years less than those without sickle cell disease? New clinical approaches and treatments can lead to increased survival. In this 30-minute CME activity, Dr Biree Andemariam and Dr Laura De Castro explore current evidence-based approaches, review available agents, and discuss strategies to encourage clinical trial participation among patients. Join us to learn the latest information on this challenging disease.

https://www.mycme.com/courses/the-time-is-now-advancing-the-care-of-adolescent-and-adult-patients-with-sickle-cell-disease-7500

 

 

Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease

/0 Comments/in /by

Acute graft-versus-host disease (aGVHD) is a common complication of allogeneic hematopoietic stem cell transplantation and is a major cause of morbidity and mortality. While systemic corticosteroids are traditional first-line treatment for aGVHD, about half of patients are refractory to therapy. So what options are available for the treatment of steroid-refractory aGVHD? Join Doris Ponce, MD, and Corey Cutler, MD, MPH, for this podcast as they discuss different novel therapeutic options for managing aGVHD refractory to steroids.

This activity is jointly provided by Global Education Group and Spire Learning.
This activity is supported by an educational grant from CSL Behring LLC and Incyte Corporation.

Click here to listen to this podcast:

https://reachmd.com/programs/cme/breakthroughs-innovations-managing-complex-cases-in-graft-versus-host-disease/11883/

Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department

/0 Comments/in /by

The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event. This interactive activity will offer clinical pearls for the assessment of bleeding severity in patients receiving DOACs; expert-guided insights to rapid reversal of urgent DOAC-associated bleeding; and clinical decision support tools to optimize outcomes in patients requiring reversal of DOACs.

To access this activity, click here:

https://www.mycme.com/courses/changing-course-reversing-direct-oral-anticoagulants-in-the-emergency-department-7315

Moving the Needle: Collaborative Strategies to Overcome Barriers to Insulin Initiation and Adherence – Gather-ed Activity

/0 Comments/in , /by

Are you confident initiating and managing insulin in your clinical practice? With the number of adults with type 2 diabetes estimated to increase to over 60 million by 2060, more patients will require insulin and more strain will be placed on clinicians in the health care system.

This educational activity will be delivered via an innovative online platform and led by faculty experts in diabetes using virtual small groups of learners to drive discussion and learning through assessments, self-study modules, group tasks, and live group discussions. Experts will address barriers to insulin uptake and adherence, strategies to address these barriers, and recommendations for the role and use of insulin.

Here is the link to sign up with additional details.  Once on the platform, pick a group to enroll in.  The groups will be kicking off in early to mid-January.  Don’t wait, sign up today!

https://spire.gathered.com/curriculum/54

 

Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care – Gather-ed Activity

/0 Comments/in , /by

The goal of this Gather-ed experience is to summarize the latest clinical evidence and recommendations for early diagnosis and aggressive management of MS. This initiative consists of self-study modules and live group discussions that briefly review relevant clinical trial findings and addresses questions clinicians commonly face in their practice.

Here is the link to sign up with additional details.  Once on the platform, pick a group to enroll in.  The groups will be kicking off in early to mid-January.  Don’t wait, sign up today!

https://spire.gathered.com/curriculum/49

 

Matching the Tool to the Job: Individualizing Treatment Strategies in Ovarian Cancer

/0 Comments/in /by

How have PARP inhibitors changed maintenance therapy for advanced ovarian cancer? Join Dr Michael Birrer and Dr Ursula Matulonis as they discuss recent clinical data related to the use of PARP inhibitors in maintenance therapy for advanced ovarian cancer, and highlight strategies to effectively prevent and manage treatment-related adverse effects.

This activity is jointly provided by Postgraduate Institute for Medicine and Spire Learning.
This activity is supported by an independent educational grant from Tesaro, a GSK company.

Click on this link to access the program:

https://www.mycme.com/courses/matching-the-tool-to-the-job-individualizing-treatment-strategies-in-ovarian-cancer-7255